ELENA MARTÍNEZ BALSALOBRE

García-Castillo J, Alcaraz-Pérez F, Martínez-Balsalobre E, García-Moreno D, Rossmann MP, Fernández-Lajarín M, Bernabé-García M, Pérez-Oliva AB, Rodríguez-Cortez VC, Bueno C, Adatto I, Agarwal S, Menéndez P, Zon LI, Mulero V, Cayuela ML. Telomerase RNA recruits RNA polymerase II to target gene promoters to enhance myelopoiesis. Proc Natl Acad Sci U S A. 2021 Aug 10;118(32). pii: e2015528118. doi: 10.1073/pnas.2015528118. PubMed PMID: 34353901; PubMed Central PMCID: PMC8364177.

AÑO: 2021; IF: 11.1

34353901

Lee L, Perez Oliva AB, Martinez-Balsalobre E, Churikov D, Peter J, Rahmouni D, Audoly G, Azzoni V, Audebert S, Camoin L, Mulero V, Cayuela ML, Kulathu Y, Geli V, Lachaud C. UFMylation of MRE11 is essential for telomere length maintenance and hematopoietic stem cell survival. Sci Adv. 2021 Sep 24;7(39):eabc7371. doi: 10.1126/sciadv.abc7371. Epub 2021 Sep 24. PubMed PMID: 34559557; PubMed Central PMCID: PMC8462904.

AÑO: 2021; IF: 14.957

34559557

Bernabé-García M, Martínez-Balsalobre E, García-Moreno D, García-Castillo J, Revilla-Nuin B, Blanco-Alcaina E, Mulero V, Alcaraz-Pérez F, Cayuela ML. Telomerase reverse transcriptase activates transcription of miR500A to inhibit Hedgehog signalling and promote cell invasiveness. Mol Oncol. 2021 Jul;15(7):1818-1834. doi: 10.1002/1878-0261.12943. Epub 2021 May 2. PubMed PMID: 33713376; PubMed Central PMCID: PMC8253104.

AÑO: 2021; IF: 6.6

33713376

Arriazu E, Vicente C, Pippa R, Peris I, Martinez-Balsalobre E, Garcia-Ramirez P, Marcotegui N, Igea A, Alignani D, Rifon J, Mateos MC, Cayuela ML, Nebreda AR, Odero MD. A new regulatory mechanism of protein phosphatase 2A activity via SET in acute myeloid leukemia. Blood Cancer J. 2020 Jan 8;10(1):3. doi: 10.1038/s41408-019-0270-0. PubMed PMID: 31913266; PubMed Central PMCID: PMC6949222.

AÑO: 2020; IF: 9.812

31913266

Vicente C, Arriazu E, Martinez-Balsalobre E, Peris I, Marcotegui N, Garcia-Ramirez P, Pippa R, Rabal O, Oyarzabal J, Guruceaga E, Prosper F, Mateos MC, Cayuela ML, Odero MD. A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity. Cancer Lett. 2020 Jan 1;468:1-13. doi: 10.1016/j.canlet.2019.10.007. Epub 2019 Oct 5. PubMed PMID: 31593801.

AÑO: 2020; IF: 9.756

31593801